Obsessive-compulsive symptoms in schizophrenia: their relationship with clinical features and pharmacological treatment

Journal of Psychiatric Practice
Giovanni NolfeGiuseppe Nolfe

Abstract

The aim of this study was to evaluate (1) the frequency of obsessive-compulsive symptoms (OCS) in patients with schizophrenia, (2) the impact of OCS on clinical features of schizophrenia, and (3) the association between type of antipsychotic treatment and presence of OCS. OCS were evaluated using the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) in 70 patients with schizophrenia. The patients were then divided into two subgroups: those with at least a moderate level of OCS and those with mild or absent OCS. The two subgroups were compared using scores on the Scale for the Assessment of Positive Symptoms (SAPS), the Scale for the Assessment of Negative Symptoms (SANS), and the Global Assessment of Functioning Scale (GAF). Of the 70 patients with schizophrenia who were evaluated, 36 (51.4%) had at least moderate OCS (Y-BOCS score >16). SAPS subscale scores for hallucinations and delusions and GAF scores were found to be significantly higher among patients with at least moderate OCS, compared with those with mild or absent OCS. A significant relationship between at least moderate OCS and treatment with conventional antipsychotics was also observed. The presence of OCS seems to have the potential to affect clinical outcomes in sch...Continue Reading

References

Nov 1, 1989·Archives of General Psychiatry·W K GoodmanD S Charney
Nov 1, 1989·Archives of General Psychiatry·W K GoodmanD S Charney
Dec 1, 1988·The American Journal of Psychiatry·L R BaxterL Fairbanks
Dec 1, 1988·Archives of General Psychiatry·M KarnoM A Burnam
Apr 1, 1986·The American Journal of Psychiatry·W S Fenton, T H McGlashan
Apr 1, 1968·The British Journal of Psychiatry : the Journal of Mental Science·C M Rosenberg
Jul 1, 1982·Archives of General Psychiatry·N C Andreasen
May 1, 1995·The British Journal of Psychiatry : the Journal of Mental Science·S H JonesG Dunn
Jan 1, 1995·Comprehensive Psychiatry·I BermanA I Green
Jul 1, 1994·Acta Psychiatrica Scandinavica·P H Thomsen, J Jensen
Feb 1, 1997·The American Journal of Psychiatry·J L EisenS A Rasmussen
Apr 1, 1998·The Journal of Nervous and Mental Disease·I BermanA I Green
Jan 14, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·S SaxenaL R Baxter
Mar 4, 2000·The Journal of Neuropsychiatry and Clinical Neurosciences·S KrügerJ Langkrär
Mar 4, 2000·The Journal of Neuropsychiatry and Clinical Neurosciences·M Y HwangM F Losconzcy
Mar 1, 2000·The Journal of Nervous and Mental Disease·P H LysakerG R Bond
Mar 30, 2000·The American Journal of Psychiatry·J J KimR D Hichwa
Apr 12, 2000·Journal of Psychiatric Research·P TibboL Warneke
Sep 19, 2000·Schizophrenia Bulletin·P C BermanzohnS G Siris
May 23, 2001·Psychiatry Research·M PoyurovskyA Weizman
Oct 3, 2001·The British Journal of Psychiatry : the Journal of Mental Science·J J KimJ S Kwon
Apr 2, 2002·The American Journal of Psychiatry·Thomas CraigEvelyn J Bromet
Sep 28, 2002·Journal of Clinical Psychopharmacology·Basil AlevizosGeorge N Christodoulou
Nov 12, 2002·The Journal of Neuropsychiatry and Clinical Neurosciences·Paul H LysakerMorris D Bell
Jan 10, 2003·Psychiatry and Clinical Neurosciences·Masayuki OhtaYoshio Morita
May 3, 2003·The American Journal of Psychiatry·Allon NechmadRonit Weizman
Jan 26, 1957·British Medical Journal·J POLLITT
Oct 1, 1957·The Journal of Mental Science·I ROSEN
May 1, 1961·The Journal of Mental Science·I M INGRAM
Oct 19, 2004·Journal of Affective Disorders·Jitender SareenJeffrey P Reiss
May 18, 2005·Psychiatry and Clinical Neurosciences·Bulent KayahanDefne Eraslan
Jun 14, 2005·Schizophrenia Research·Matthew ByerlyA John Rush
Jul 6, 2007·Psychiatry and Clinical Neurosciences·Toshiki ShioiriToshiyuki Someya
Jun 30, 2009·Schizophrenia Research·Francois GuillemEmmanuel Stip

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here